Serum proteomic, peptidomic and metabolomic profiles in myasthenia gravis patients during treatment with Qiangji Jianli Fang
Publication in refereed journal

Times Cited
Web of Science4WOS source URL (as at 16/09/2020) Click here for the latest count
Altmetrics Information

Other information
AbstractBackground: Qiangji Jianli Fang (QJF) has been used for treatment of myasthenia gravis (MG) in China. However, our understanding of the effects of QJF against MG at the molecular level is limited. This study aims to investigate the effects of QJF treatment of MG patients on the protein, peptide and metabolite levels in serum.
All Author(s) ListWang CM, Lu YH, Chen ZX, Liu XB, Lin HQ, Zhao H, Chen JY, Kwan YW, Ngai S
Journal nameChinese Medicine
Detailed descriptionTo ORKTS: doi:10.1186/1749-8546-7-16
Volume Number7
PublisherBioMed Central
LanguagesEnglish-United Kingdom
Web of Science Subject CategoriesIntegrative & Complementary Medicine; Pharmacology & Pharmacy

Last updated on 2020-17-09 at 01:43